ContraFect to Present New Clinical and Microbiological Data on CF-301 at ASM Microbe 2017
ContraFect Corporation (CFRX)
Last contrafect corporation earnings: 3/18 07:00 am
Check Earnings Report
US:NASDAQ Investor Relations:
ir.contrafect.com
Company Research
Source: Marketwire
YONKERS, NY -- (Marketwired) -- 06/01/17 -- ContraFect Corporation (NASDAQ: CFRX), a biotechnology company focused on the discovery and development of protein and antibody therapeutics for life-threatening, drug-resistant infectious diseases, today announces five poster presentations of new data from the CF-301 development program at the American Society for Microbiology (ASM) Microbe 2017 conference to be held on June 1-5, 2017 in New Orleans, LA. ContraFect's lead compound, CF-301 is the first member of the lysin class to enter Phase 2 of clinical development in the US for the treatment of Staphylococcus aureus (Staph aureus) bacteremia including endocarditis. Initial data from the Phase 1, first-in-human study of CF-301 in healthy volunteers, presented in 2016, demonstrated CF-301 to be well-tolerated with no clinical adverse safety signals. New analyses of clinical data from this Phase 1 trial which further support the safety profile of C
Show less
Read more
Impact Snapshot
Event Time:
CFRX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CFRX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CFRX alerts
High impacting ContraFect Corporation news events
Weekly update
A roundup of the hottest topics